Clinical Trials Directory

Trials / Unknown

UnknownNCT02290704

Retinal Oxygen Saturation in Patients With Graves' Ophthalmopathy and in Normal People

Changes of Retinal Oxygen Saturation in Patients With Graves' Ophthalmopathy Under Different Managing Conditions and in Normal People

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Find if the retinal function is affected in both the nonsevere and the severe stage of Graves' ophthalmopathy (GO) by comparing the retinal oxygen saturation of GO patients with that of normal people.

Detailed description

Graves'ophthalmopathy (GO), also called thyroid-associated ophthalmopathy, is often mild and self-limiting, and probably declining in frequency, with only 3-5% of cases posing a threat to eyesight, remaining a pathogenetic enigma and a therapeutic dilemma. In its nonsevere expression, the symptoms and signs include Photophobia, Foreign body sensation, Eyelid retraction, increased intraocular pressure, Lagophthalmos, and Mild diplopia. In its severe expression, it is a disfiguring and invalidating disease with the optic nerve damaged. However, in this study, we want to find if the retinal vessels is affected in the early stage of the disease through observing the oxygen saturation of the retinal vessels and compare it with that of the normal people.

Conditions

Timeline

Start date
2014-01-01
Primary completion
2017-11-01
Completion
2017-11-01
First posted
2014-11-14
Last updated
2017-11-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02290704. Inclusion in this directory is not an endorsement.